Gerrit Dispersyn

Chief Development Officer, Phio Pharmaceuticals Corp.

Companies

Phio Pharmaceuticals Corp.Board member Mar 3, 2021 to Mar 3, 2022¹
Phio Pharmaceuticals Corp.Chief executive officer Mar 5, 2019 to Mar 3, 2022²
Phio Pharmaceuticals Corp.President Feb 15, 2019 to Mar 3, 2022³
Phio Pharmaceuticals Corp.Chief operating officer Feb 15, 2019 to Feb 15, 2019³
Phio Pharmaceuticals Corp.Chief Development Officer Apr 26, 2017 to Aug 3, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Phio Pharmaceuticals Corp. PHIO212,327 shares⁵$196.6K at $0.93Mar 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2022Shares withheld for tax 8,954 shares at $0.82 of Phio Pharmaceuticals Corp.⁵
Feb 15, 2022Granted 126,000 shares of Phio Pharmaceuticals Corp.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPhio Pharmaceuticals Corp., Board member
2
SEC EDGARPhio Pharmaceuticals Corp., Chief executive officer
3
SEC EDGARPhio Pharmaceuticals Corp., President
4
SEC EDGARPhio Pharmaceuticals Corp., Chief Development Officer
5
SEC EDGARPhio Pharmaceuticals Corp. shares after the filing of Mar 1, 2022
6
SEC EDGARForm 4 filed Feb 16, 2022